FOUNDERS

Andrew J. Koval

Mr. Koval brings over twenty-five years’ experience in international development. Whether as the Regional Director for International Development in the Middle East and North Africa (MENA), developing the programming activities of 19 countries or as the Director of the Africa Development Group, where he conceptualized and implemented a long-term development strategy for the Africa Development Fund, Mr. Koval has always championed the needs of the developing world.

As the CEO of MedPharm, he has grown the organization into a preeminent provider of a wide range of products and services to emerging markets, to Non-Profit and Non-Government Organizations (NGOs) and Foundations, to official organizations of the United Nations (WHO, WFP, UNICEF, PAHO and PAHEF), to projects funded or supported by U.S. government agencies (USAID, OFDA, State Department’s PRM, USDA and the Department of Defense), and to the Ministries of Health.

Expanding on such exemplary achievements, Mr. Koval sees NGOPharmacy as a natural extension of his life’s work. A means to continue to offer world class products, promote global philanthropy and see to the eradication of certain neglected tropical diseases.

Joseph Trentin

Mr. Trentin has more than 20 years of international business experience. A former professional baseball player for the Chicago White Sox, Mr. Trentin has served as Special Assistant to the Governor of Texas; Director of the World Trade Center in New Orleans and was appointed by the U.S. Department of Commerce to the Directorship of the International Business center for the World Fair. He has consulted for multinational conglomerates such as Smith Kline Beecham and Sumitomo Corporation to develop non-traditional markets for their products in Africa and Latin America. He also successfully completed the world’s first Debt for Health swap in Ecuador.

As co-founder and CFO of NGOPharmacy.com, Mr. Trentin is committed to bringing his diverse international experience to the fore. His unique know how and perspective will allow the company to develop and expand on a global scale.